PULSION Medical Systems SE (MU:PUS) — Market Cap & Net Worth
Market Cap & Net Worth: PULSION Medical Systems SE (PUS)
PULSION Medical Systems SE (MU:PUS) has a market capitalization of $178.09 Million (€152.33 Million) as of June 19, 2026. Listed on the MU stock exchange, this Germany-based company holds position #17105 globally and #1609 in its home market, demonstrating a 2.86% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying PULSION Medical Systems SE's stock price €21.60 by its total outstanding shares 8244914 (8.24 Million). Review PULSION Medical Systems SE total liabilities to assess the company's total debt and financial obligations.
PULSION Medical Systems SE Market Cap History: 2015 to 2025
PULSION Medical Systems SE's market capitalization history from 2015 to 2025. Data shows change from $214.71 Million to $208.21 Million (-0.10% CAGR).
PULSION Medical Systems SE Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how PULSION Medical Systems SE's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
3.83x
PULSION Medical Systems SE's market cap is 3.83 times its annual revenue
Latest Price to Earnings (P/E) Ratio
281.37x
PULSION Medical Systems SE's market cap is 281.37 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $214.71 Million | $25.88 Million | $35.59 Million | 8.30x | 6.03x |
| 2019 | $180.81 Million | $25.53 Million | $771.20K | 7.08x | 234.45x |
| 2020 | $189.50 Million | $32.06 Million | $122.01K | 5.91x | 1553.17x |
| 2021 | $168.64 Million | $27.95 Million | $1.07 Million | 6.03x | 157.00x |
| 2022 | $165.15 Million | $29.66 Million | $987.56K | 5.57x | 167.23x |
| 2023 | $145.95 Million | $35.80 Million | -$2.95 Million | 4.08x | N/A |
| 2024 | $153.26 Million | $39.99 Million | $544.70K | 3.83x | 281.37x |
Competitor Companies of PUS by Market Capitalization
Companies near PULSION Medical Systems SE in the global market cap rankings as of June 19, 2026.
Key companies related to PULSION Medical Systems SE by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #147 globally with a market cap of $153.73 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #207 globally with a market cap of $117.79 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #234 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #247 globally with a market cap of $101.86 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #147 | Abbott Laboratories | NYSE:ABT | $153.73 Billion | $88.41 |
| #207 | Stryker Corporation | NYSE:SYK | $117.79 Billion | $307.80 |
| #234 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #247 | Medtronic PLC | NYSE:MDT | $101.86 Billion | $79.34 |
PULSION Medical Systems SE Historical Marketcap From 2015 to 2025
Between 2015 and today, PULSION Medical Systems SE's market cap moved from $214.71 Million to $ 208.21 Million, with a yearly change of -0.10%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | €208.21 Million | +35.85% |
| 2024 | €153.26 Million | +5.01% |
| 2023 | €145.95 Million | -11.63% |
| 2022 | €165.15 Million | -2.07% |
| 2021 | €168.64 Million | -11.01% |
| 2020 | €189.50 Million | +4.81% |
| 2019 | €180.81 Million | -7.96% |
| 2018 | €196.45 Million | -11.67% |
| 2017 | €222.40 Million | +8.87% |
| 2016 | €204.28 Million | -4.86% |
| 2015 | €214.71 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 19th, 2026 the market cap of PULSION Medical Systems SE was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $178.09 Million USD |
| MoneyControl | $178.09 Million USD |
| MarketWatch | $178.09 Million USD |
| marketcap.company | $178.09 Million USD |
| Reuters | $178.09 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About PULSION Medical Systems SE
PULSION Medical Systems SE engages in the development, production, and distribution of monitoring, diagnostic, and therapy control systems for recording physiological parameters of hospitalized, seriously ill, and intensive care patients. Its technologies include the PiCCO2 platform, a system used in intensive care medicine for the treatment of critically ill patients; PulsioFlex, which offers te… Read more